HCPCS Level IIdrugActive
J0695
Inj ceftolozane tazobactam
BETOS: O1E
Effective: 2016-01-01
Description
Injection, ceftolozane 50 mg and tazobactam 25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Zerbaxa
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
75MG (50MG cft/25MG taz)
Billing Units
20.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.